Clinical Trials Logo

Intraocular Lens Complication clinical trials

View clinical trials related to Intraocular Lens Complication.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06396156 Completed - Clinical trials for Corneal Endothelial Cell Loss

Anterior Versus Posterior Artisan Intraocular Lens Fixation in Aphakic Children With Insufficient Capsular Support.

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The Artisan lens (Artisan Aphakic, Ophtec BV) is an iris- claw lens designed for implantation in children with insufficient capsular support. In spite of less surgical manipulations and a relatively shorter operation time, the procedure carries the risk of corneal endothelial cell loss or dis-enclavation, particularly in children. However, most of the studies that studied iris-claw lenses in aphakic children were retrospective evaluated only a single technique; either anterior or retropupillary fixation, or comparable to other techniques of fixation. Thus the aim of this work is to prospectively compare the 2 techniques of iris-claw lens implantation and their effects on central endothelial cell density, the anatomical and visual outcome, as well as the complications' rate.

NCT ID: NCT06196593 Completed - Cataract Senile Clinical Trials

Visual Outcomes Following Bilateral Implantation of the Vivity Toric Intraocular Lens

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

The objective of this study was to evaluate the clinical and patient reported outcomes after bilateral implantation of the AcrySof™ IQ Vivity™ Toric intraocular lens.

NCT ID: NCT05750225 Completed - Cataract Clinical Trials

Clinical Investigation of the Safety and Performance of Model 690AD and Model 690ADY Monofocal Intraocular Lens Implantation

Start date: February 2, 2023
Phase:
Study type: Observational

Medicontur hydrophilic posterior chamber monofocal intraocular lens (IOLs) are indicated to improve vision at far distance in adults with cataract and/or ametropia (hyperopia, myopia), secondarily to removal of the crystalline lens. The intraocular lens is intended to be surgically implanted into the eye with the purpose of restoring optical function in the aphakic eye to provide an optical system with high predictability of the precalculated dioptric power. The study will be performed partially as a retrospective study with patients enrolled who had been implanted with 690AD or 690ADY IOLs mono- or binocularly between September 2021 - March 2022. Data from five visits will be collected: - Baseline preoperative (maximum 90 days prior to surgery)- retrospective - IOL implantation Day 0 - retrospective - Postoperative visit at Day 1 (+/- 0 days) - retrospective - Postoperative visit at 1 month (+/- 2 weeks) - retrospective - Postoperative visit at 12 months (+/- 3 months) - consent and prospective visit

NCT ID: NCT05278949 Completed - Clinical trials for Intraocular Lens Complication

Re-fixating Dislocated Scleral Fixing Intra-ocular Lens

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

To minimize multiple manipulations and to decrease the economical burden; here, we describe how to utilize the patient's own dislocated intraocular lens to re-fixate with the sclera.

NCT ID: NCT04971863 Completed - Cataract Clinical Trials

In-vivo Behavior of Asqelio Monofocal Biaspheric Intraocular Lens

Start date: March 30, 2022
Phase:
Study type: Observational

This is a study to evaluate the 24 month postoperative incidence and intensity of posterior capsular opacity in patients submitted to cataract surgery and implanted with a hydrophobic monofocal IOL.